相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Oral Antibiotic Exposure and Kidney Stone Disease
Gregory E. Tasian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Gender Equivalence in the Prevalence of Nephrolithiasis among Adults Younger than 50 Years in the United States
Gina Tundo et al.
JOURNAL OF UROLOGY (2018)
Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion
Felix Knauf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
The Cystic Fibrosis Foundation Patient Registry Design and Methods of a National Observational Disease Registry
Emily A. Knapp et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Renal diseases in adults with cystic fibrosis: a 40 year single centre experience
M. J. Wilcock et al.
JOURNAL OF NEPHROLOGY (2015)
The role of Oxalobacter formigenes colonization in calcium oxalate stone disease
Roswitha Siener et al.
KIDNEY INTERNATIONAL (2013)
Prevalence of Kidney Stones in the United States
Charles D. Scales et al.
EUROPEAN UROLOGY (2012)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The association of nephrolithiasis with cystic fibrosis
EM Gibney et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Time trends in reported prevalence of kidney stones in the United States: 1976-1994
KK Stamatelou et al.
KIDNEY INTERNATIONAL (2003)
Metabolic risk factors for stone formation in patients with cystic fibrosis
MR Perez-Brayfield et al.
JOURNAL OF UROLOGY (2002)
Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis
H Bohles et al.
JOURNAL OF PEDIATRICS (2002)
分享论文
